Page last updated: 2024-08-24

rhodamine 123 and Uterine Neoplasms

rhodamine 123 has been researched along with Uterine Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beketic-Oreskovic, L; Chen, GK; DurĂ¡n, GE; Mangili, A; Sikic, BI1

Other Studies

1 other study(ies) available for rhodamine 123 and Uterine Neoplasms

ArticleYear
MDR 1 activation is the predominant resistance mechanism selected by vinblastine in MES-SA cells.
    British journal of cancer, 2000, Volume: 83, Issue:7

    Topics: Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Cyclosporins; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Etoposide; Female; Gene Expression Regulation, Neoplastic; Genes, MDR; Humans; Multidrug Resistance-Associated Proteins; Mutation; Neoplasm Proteins; Paclitaxel; Phenotype; Rhodamine 123; RNA, Messenger; Sarcoma; Tritium; Tumor Cells, Cultured; Uterine Neoplasms; Vault Ribonucleoprotein Particles; Vinblastine

2000